News
U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline ...
Senator Maggie Hassan is investigating GSK's discontinuation of Flovent HFA, citing increased hospitalizations, higher drug ...
Amid ongoing controversy, U.S. Sen. Maggie Hassan (D-N.H.) is investigating GSK for replacing a popular asthma inhaler with a ...
U.S. Senator Maggie Hassan has initiated an investigation into GlaxoSmithKline's decision to discontinue the Flovent HFA ...
When Donald Trump unveiled his “One Big Beautiful Bill” last month, all the focus was on how the president’s trillions of tax ...
The report highlights that 14 percent of UK GCCs in India belong to Fortune Global 500 firms, and nearly 95 percent are ...
Business intelligence (BI) has emerged as a critical component of profitable corporate operations in today's data-driven ...
From drug trials to mechanistic insights, EULAR 2025 delivers wide-ranging data that may inform tomorrow’s standards in ...
9h
EURweb on MSNSarah Borne Talks ‘Pretty Hurts’ Role and Raising Awareness About Meningitis | EUR Video ExclusiveSarah Borne discusses her role as Lauren in 'Pretty Hurts,' a Lifetime movie that blends pageant drama with meningitis awareness.
By Mariam Sunny and Mrinalika Roy (Reuters) -Shares of Gilead rose 3% after the U.S. Supreme Court on Friday upheld a federal ...
Sales of GSK's respiratory syncytial virus (RSV) vaccine Arexvy slumped 72% in the third quarter of this year, as narrower recommendations on its use in the US started to have an effect.
GSK has said it expects Blenrep to achieve peak annual sales of around £3 billion (nearly $4 billion). It also plans to continue working on Blenrep's comeback with the DREAMM-10 study in newly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results